We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Research article: Sustainable PFAS-free alternatives for TFA in SPPS
9 Aug 2024 - With growing manufacturing volumes, PolyPeptide remains dedicated to applying relevant principles of green chemistry. We are proud of our scientists pushing the frontiers and actively contributing […]
Read morePolyPeptide appoints Chief Commercial Officer
8 Aug 2024 - Baar, 8 August 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced the appointment of […]
Read moreAdvancing Sustainable Peptide Synthesis by Solvent Quality Control: Understanding and Mitigating Hydroperoxide in 1-Butyl-2-pyrrolidinone (NBP)
25 Jul 2024 - Org. Process Res. Dev. 2024, 28, 3347–3367 Pawlas, J.; Mohy El-Dine, T.; von Bargen, K.; von Bargen, C.; Nilsson, J.; Ludemann-Hombourger, O.; Rasmussen, J. H. See […]
Read moreTrending topics at PolyPeptide
17 Jun 2024 - We are proud of our colleagues who regularly present at industry conferences to share their latest expert insights and experience in peptide manufacturing. Four of them […]
Read morePolyPeptide and Donaldson collaborate to develop solvent recovery system for peptide purification
13 May 2024 - MINNEAPOLIS / TORRANCE, Calif. May 13, 2024 – Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and […]
Read moreResearch article: Synthesis of Peptides by Reactive Extrusion. Application to the Continuous and Solventless Preparation of Aspartame.
25 Apr 2024 - The latest results from an innovative mechanochemical approach to continuous and solventless peptide synthesis. PolyPeptide is dedicated to applying relevant principles of green chemistry to mitigate […]
Read morePolyPeptide announces results of the annual General Meeting 2024
10 Apr 2024 - Baar, 10 April 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced that the shareholders […]
Read morePolyPeptide participates in industry effort to advance sustainability
26 Mar 2024 - Increasing manufacturing volume requirements and the high process mass intensity (PMI) of peptide synthesis warrants continued industry efforts for more sustainable production processes. PolyPeptide collaborated with […]
Read morePolyPeptide publishes invitation to the annual General Meeting 2024
19 Mar 2024 - Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, published today the invitation to […]
Read more